$88.4 Million is the total value of PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's 17 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 44.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IRIX | Sell | IRIDEX CORP | $6,003,000 | -13.3% | 783,625 | -20.1% | 6.79% | -26.3% |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $4,693,000 | -51.3% | 46,646 | -31.5% | 5.31% | -58.6% |
CS | Sell | CREDIT SUISSE GROUPsponsored adr | $1,972,000 | -37.3% | 200,000 | -33.3% | 2.23% | -46.7% |
ATNI | Sell | ATN INTL INC | $394,000 | -3.7% | 8,400 | -6.7% | 0.44% | -18.2% |
MLHR | Sell | MILLER HERMAN INC | $377,000 | -95.2% | 10,000 | -93.9% | 0.43% | -95.9% |
LUMO | Exit | LUMOS PHARMA INC | $0 | – | -50,000 | -100.0% | -0.66% | – |
KNL | Exit | KNOLL INC | $0 | – | -50,000 | -100.0% | -1.73% | – |
CI | Exit | CIGNA CORP NEW | $0 | – | -11,500 | -100.0% | -3.63% | – |
BK | Exit | BANK NEW YORK MELLON CORP | $0 | – | -125,000 | -100.0% | -8.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NAVIGATOR HOLDINGS LTD | 40 | Q3 2023 | 38.2% |
IRIDEX CORP | 40 | Q3 2023 | 23.4% |
COMMUNITY BANKERS TR CORP | 28 | Q3 2020 | 10.5% |
PAR PETROLEUM CORP | 26 | Q2 2020 | 15.3% |
REATA PHARMACEUTICALS INC | 22 | Q3 2021 | 34.4% |
EPSILON ENERGY LTD | 19 | Q3 2023 | 16.6% |
CAREDX INC | 16 | Q2 2019 | 6.6% |
FORESTAR GROUP INC | 16 | Q4 2019 | 3.0% |
SPDR S&P 500 ETF TR | 13 | Q3 2022 | 34.2% |
HOWARD HUGHES CORP | 13 | Q1 2019 | 5.5% |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Epsilon Energy Ltd. | June 12, 2023 | 900,000 | 3.9% |
IRIDEX CORP | November 23, 2022 | 963,250 | 6.0% |
CareDx, Inc. | January 24, 2018 | 1,133,000 | 3.9% |
CASCADE MICROTECH INC | November 04, 2014 | 950,000 | 5.8% |
SPECTRANETICS CORP | October 02, 2012 | 1,700,000 | 4.9% |
DUSA PHARMACEUTICALS INC | May 26, 2011 | 1,218,500 | 5.0% |
SENORX INC | May 07, 2010 | 140,993 | 0.8% |
TRANSCOMMUNITY FINANCIAL CORP | March 21, 2008 | 445,000 | 9.7% |
ARONEX PHARMACEUTICALS INC | January 25, 2000 | 1,138,111 | 5.0% |
APPLIED IMAGING CORP | January 20, 2000 | 483,833 | 4.0% |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-06-12 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
SC 13D | 2022-11-23 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-16 |
View PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.